01—Abstract
Summary
Summary of the 10-K/A filed April 12, 2004. Cited figures are marked; the original filing is the authoritative source.
This filing is Amendment No. 1 to the Form 10-K of Charles River Laboratories International, Inc. for the fiscal year ended December 27, 2003, signed April 8, 2004 and filed on April 12, 2004.
The company is a Delaware corporation headquartered in Wilmington, Massachusetts, with common stock listed on the New York Stock Exchange. The amendment does not change the original report; its sole stated purpose is to remove the check mark from the cover-sheet box relating to Item 405 of Regulation S-K. The original Form 10-K was filed with the SEC on March 10, 2004.
According to the filing, the aggregate market value of common stock held by non-affiliates was approximately $1,453,176,300a as of June 28, 2003, and 46,074,943 shares were outstanding as of March 3, 2004. Portions of the Definitive Proxy Statement for the 2004 Annual Meeting of Stockholders, scheduled for May 12, 2004, are incorporated by reference into Part III. This amendment contains no financial statements, operating results, or business discussion.
It is signed by James C. Foster, President, Chief Executive Officer and Chairman, and Thomas F. Ackerman, Senior Vice President and Chief Financial Officer, along with the board of directors, and it includes certifications under Rules 13a-14(a) and 15d-14(a) and Section 1350 as exhibits.
02—Key points
Key Highlights
- Filing type: Amendment No. 1 to the Form 10-K for the fiscal year ended December 27, 2003, filed April 12, 2004
- Sole change: removes the check mark from the cover-sheet box relating to Item 405 of Regulation S-K; otherwise the Form 10-K is not amended
- Original Form 10-K was filed with the SEC on March 10, 2004
- Non-affiliate market value of common stock was approximately $1,453,176,300 as of June 28, 2003
- 46,074,943 common shares outstanding as of March 3, 2004 ($0.01 par value), listed on the New York Stock Exchange
- Part III information is incorporated by reference from the 2004 Proxy Statement for the May 12, 2004 annual meeting
- Certifications filed as exhibits: Rule 13a-14(a)/15d-14(a) certifications of the CEO and CFO and Section 1350 certifications
03—Questions
Frequently Asked Questions
What changed in this amended 10-K?
According to the explanatory note, the amendment only removes the check mark from the cover-sheet box relating to Item 405 of Regulation S-K. The company states that the Form 10-K is otherwise not amended in any way.
Does this filing contain financial results for fiscal 2003?
This amendment does not include financial statements or operating results. It consists of the cover page, explanatory note, signatures, and exhibit index referencing the officer certifications.
Where is the company's corporate information for governance matters such as executive compensation?
The filing states that portions of the Definitive Proxy Statement for the 2004 Annual Meeting of Stockholders, scheduled for May 12, 2004, are incorporated by reference into Part III of the Annual Report on Form 10-K.
Who signed the amended filing?
The filing was signed on April 8, 2004 by James C. Foster (President, Chief Executive Officer and Chairman), Thomas F. Ackerman (Senior Vice President and Chief Financial Officer), and directors Robert Cawthorn, Stephen D. Chubb, George E. Massaro, George M. Milne, Douglas E. Rogers, Samuel O. Thier, and William H. Waltrip.
04—Continue